Ongoing, recruitingTherapeutic exploratory (Phase II)Interventional

Exploratory pilot study to determine the tolerability and effectiveness of Tirbanibulin in the treatment of Actinic Cheilitis

At a glance

Status

Ongoing, recruiting

Phase

Therapeutic exploratory (Phase II)

Sponsor

Technische Universitat Dresden

Enrolment target

Start

17 Jul 2023

Actinic Cheilitis

What is this study about?

Complete recovery rate (healing) of Actinic Cheilitis, 8 weeks after the application of Tirbanibulin for 5 days (visit 4, day 56). Complete recovery is defined as an affected area of 0 cm.

Who may be eligible?

Age 18 Years to any · Sex: All

Locations (1)

—
Germany

How to find out more

Official trial record

Always speak to your GP or specialist before deciding to take part in a study.